What is she best known for?
The fields of study she is best known for:
- Gene
- Internal medicine
- Endocrinology
Her main research concerns Closed head injury, Traumatic brain injury, Pharmacology, Endocrinology and Internal medicine.
Her Closed head injury research is multidisciplinary, relying on both Anesthesia, Central nervous system disease, Cytokine, Edema and Pathology.
Her study in Traumatic brain injury is interdisciplinary in nature, drawing from both Reactive oxygen species, Pharmacological therapy, Physical therapy and Ischemia.
Her research on Pharmacology focuses in particular on Neuroprotection.
Her studies deal with areas such as Lesion and Osteoblast as well as Endocrinology.
In her research on the topic of Internal medicine, In vivo, Toxicity, Nap, Apolipoprotein B and Apolipoprotein E is strongly related with Head trauma.
Her most cited work include:
- An endogenous cannabinoid (2-AG) is neuroprotective after brain injury (620 citations)
- Peripheral cannabinoid receptor, CB2, regulates bone mass (412 citations)
- Dual role of tumor necrosis factor alpha in brain injury (371 citations)
What are the main themes of her work throughout her whole career to date?
Esther Shohami focuses on Internal medicine, Endocrinology, Traumatic brain injury, Closed head injury and Neuroprotection.
Her Ischemia, Dexamethasone and Uric acid study in the realm of Internal medicine connects with subjects such as Ascorbic acid.
In the field of Endocrinology, her study on Oxidative stress, Prostaglandin E2 and Prostaglandin overlaps with subjects such as Eicosanoid.
Her research in Traumatic brain injury intersects with topics in Brain damage, Neuroscience, Inflammation, Neuroinflammation and Glutamate receptor.
Her work is dedicated to discovering how Closed head injury, Anesthesia are connected with NMDA receptor and Antagonist and other disciplines.
Her study with Neuroprotection involves better knowledge in Pharmacology.
She most often published in these fields:
- Internal medicine (34.26%)
- Endocrinology (33.86%)
- Traumatic brain injury (28.69%)
What were the highlights of her more recent work (between 2010-2021)?
- Traumatic brain injury (28.69%)
- Neuroprotection (27.89%)
- Neuroscience (15.14%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Traumatic brain injury, Neuroprotection, Neuroscience, Pharmacology and Anesthesia.
Her Traumatic brain injury research is multidisciplinary, incorporating elements of Stroke, Internal medicine, Lesion and Endocrinology.
Her Neuroprotection research is multidisciplinary, relying on both Neurogenesis, Biochemistry, Endocannabinoid system and Nerve growth factor.
Her Neuroscience study combines topics from a wide range of disciplines, such as Glutamate receptor, Long-term potentiation, Neuroinflammation and NMDA receptor.
Esther Shohami combines subjects such as Edema, Cord blood, Receptor, Neurotrophin and Ischemia with her study of Pharmacology.
Her Anesthesia research integrates issues from Inflammation, Brain lesions and Surgery.
Between 2010 and 2021, her most popular works were:
- Endocannabinoids and traumatic brain injury (107 citations)
- CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury (83 citations)
- CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts. (60 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Biochemistry
Her primary scientific interests are in Traumatic brain injury, Neuroprotection, Anesthesia, Neuroscience and Stroke.
Her Traumatic brain injury research includes elements of Cancer research, Cortex, Ischemia, Proinflammatory cytokine and Neural stem cell.
The subject of her Neuroprotection research is within the realm of Pharmacology.
Her study in Pharmacology is interdisciplinary in nature, drawing from both Protein Kinase M and Edema.
The study incorporates disciplines such as Gliogenesis, Lesion, Endocrinology and Internal medicine in addition to Anesthesia.
Her Stroke study integrates concerns from other disciplines, such as Closed head injury, Histone, Clinical trial and Central nervous system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
